MALCOLM DOUGLAS: Open Payments
NPI 1730852021 · NELLIS AFB, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 36 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $321 |
| ViiV Healthcare Company | 7 | $241 |
| Amgen Inc. | 5 | $201 |
| Gilead Sciences, Inc. | 5 | $128 |
| Exact Sciences Corporation | 4 | $59 |
| Antares Pharma, Inc. | 3 | $58 |
| Intra-Sana Laboratories | 2 | $38 |
| Astellas Pharma US Inc | 1 | $30 |
| PFIZER INC. | 1 | $29 |
| Novo Nordisk Inc | 1 | $28 |
Products named: QULIPTA, APRETUDE, KRYSTEXXA, XYOSTED, The Cologuard Plus Collection Kit, RELTONE 200 MG, OTEZLA, UBRELVY.
Industry payments across NV — which companies pay providers there.
